These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 30758835)

  • 1. Time from referral to ovarian tissue cryopreservation in a cohort of Danish women.
    Kristensen SG; Pors SE; Poulsen LC; Andersen ST; Wakimoto Y; Yding Andersen C
    Acta Obstet Gynecol Scand; 2019 May; 98(5):616-624. PubMed ID: 30758835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.
    Poirot C; Brugieres L; Yakouben K; Prades-Borio M; Marzouk F; de Lambert G; Pacquement H; Bernaudin F; Neven B; Paye-Jaouen A; Pondarre C; Dhedin N; Drouineaud V; Chalas C; Martelli H; Michon J; Minard V; Lezeau H; Doz F; Sarnacki S; Philippe-Chomette P; Dufour C; Laurence V; Baruchel A; Wolf JP; Boissel N; Valteau-Couanet D; Dalle JH
    Acta Obstet Gynecol Scand; 2019 May; 98(5):630-637. PubMed ID: 30919447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
    Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
    Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development.
    Jensen AK; Rechnitzer C; Macklon KT; Ifversen MR; Birkebæk N; Clausen N; Sørensen K; Fedder J; Ernst E; Andersen CY
    Hum Reprod; 2017 Jan; 32(1):154-164. PubMed ID: 27816923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
    Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
    Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
    Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
    Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
    Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
    Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
    Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
    J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
    Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
    J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of fertility preservation procedures in a cohort of female patients with cancer.
    Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
    Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
    Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of deaths in a cohort of girls and women with cryopreserved ovarian tissue.
    Macklon KT
    Acta Obstet Gynecol Scand; 2019 May; 98(5):625-629. PubMed ID: 30770545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of random-start controlled ovarian stimulation in cancer patients.
    Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
    J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.